Innate Pharma

Stocks

Market Closed - Euronext Paris 16:55:00 19/08/2026 BST			After hours 18:22:02
1.784 ^EUR	+0.56%		1.784	0.00%

08-14	Innate Pharma S.A. - Special Call
08-14	Innate launches a share issuance project

Published on 08/14/2026 at 05:05 pm BST

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Hello, everyone. Thank you for joining us, and welcome to the Innate Pharma webcast call. [Operator Instructions] I will now hand the conference over

This article is reserved for our subscribers.

To unlock the article,
subscribe!

Full unlimited browsing across the entire site

Access to all the news and all the data

Access to US, EUROPE AND ASIA Portfolios

Zero Ads for a completely uninterrupted reading experience

Pro Tools: Expert insights, Expert Screeners, historical financial data and reports, thematic lists, transcripts...

08-14	Innate Pharma S.A. - Special Call
08-14	Innate launches a share issuance project
08-14	Innate Pharma Seeks to Raise EUR23 Million from Share Offering	MT
08-11	Leerink Partners Upgrades Innate Pharma to Outperform From Market Perform, Adjusts PT to $4 From $3	MT
08-10	The Stockholm stock exchange opened the week slightly lower, the OMXS30 index fell 0.2 percent	FW
08-10	Swedish Orphan Biovitrum AB And Innate Pharma SA Enter Strategic Partnership To License Lacutamab In T-Cell Lymphoma	CI
08-10	Innate Pharma SA Announces Executive Changes, Effective September 1, 2026	CI
08-10	Innate Pharma Advances Lacutamab Towards Tellomak-3 Phase 3 Following Partnership with Sobi	CI
08-10	Innate Pharma S.A. and Swedish Orphan Biovitrum AB Enter Licensing Agreement for Lacutamab in T-Cell Lymphoma	CI
08-10	Mixed trade on the Stockholm Stock Exchange, the OMXS30 index slips 0.1%	FW
08-10	European stock markets: a mixed session amid tensions in the Strait of Hormuz
08-10	Innate Pharma, Sobi Partner on Late-Stage Study for Lacutamab	MT
08-10	Innate and chips shine, Porsche Automobil hits the brakes
08-10	Innate Pharma surges after a deal that secures its cash runway for another year
08-10	Innate Pharma, Swedish Orphan Biovitrum Partner to Advance Phase 3 Lymphoma Drug; Shares Surge Pre-Bell	MT